Literature DB >> 10547249

Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen.

A P Feranchak1, M K Sontag, J S Wagener, K B Hammond, F J Accurso, R J Sokol.   

Abstract

OBJECTIVE: To prospectively evaluate the biochemical status of vitamins A, D, and E in children with cystic fibrosis (CF).
SUBJECTS: A total of 127 infants identified by the Colorado CF newborn screening program.
DESIGN: Vitamin status (serum retinol, 25-hydroxy vitamin D, ratio of alpha-tocopherol/total lipids) and serum albumin were assessed at diagnosis (4 to 8 weeks), ages 6 months, 12 months, and yearly thereafter, to age 10 years.
RESULTS: Deficiency of 1 or more vitamins was present in 44 (45.8%) of 96 patients at age 4 to 8 weeks as follows: vitamin A 29.0%, vitamin D 22.5%, and vitamin E 22.8%. Of these patients with initial deficiency, the percent that was deficient at 1 or more subsequent time points, despite supplementation, was vitamin A 11.1%, vitamin D 12.5%, and vitamin E 57.1%. Of the initial patients with vitamin sufficiency, the percent who became deficient at any time during the 10-year period was as follows: vitamin A 4.5%, vitamin D 14.4%, and vitamin E 11.8%. The percent of patients deficient for 1 or more vitamins ranged from 4% to 45% for any given year.
CONCLUSIONS: Despite supplementation with standard multivitamins and pancreatic enzymes, the sporadic occurrence of fat-soluble vitamin deficiency and persistent deficiency is relatively common. Frequent and serial monitoring of the serum concentrations of these vitamins is therefore essential in children with CF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547249     DOI: 10.1016/s0022-3476(99)70059-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

1.  Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.

Authors:  Paul Beringer; Kitty My Tu Huynh; Jane Kriengkauykiat; Luke Bi; Nils Hoem; Stan Louie; Emily Han; Thao Nguyen; Donald Hsu; Purush A Rao; Bertrand Shapiro; Mark Gill
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Selection bias and vitamin E status in cystic fibrosis.

Authors:  Ronald J Sokol
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

3.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

4.  Early severe anemia as the first sign of cystic fibrosis.

Authors:  Tugba Sismanlar; Ayşe Tana Aslan; Mehmet Köse; Sevgi Pekcan; Fatih Süheyl Ezgü; Işıl İrem Budakoğlu; İdil Yenicesu
Journal:  Eur J Pediatr       Date:  2016-08-05       Impact factor: 3.183

5.  Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients.

Authors:  Konstantinos Papas; John Kalbfleisch; Ricky Mohon
Journal:  Dig Dis Sci       Date:  2007-01-10       Impact factor: 3.199

6.  Role of electroretinography in the assessment of retinal function as an indicator of vitamin A status.

Authors:  I Tsinopoulos; S Nousia-Arvanitakis; A Galli-Tsinopoulou; N Roubies; K Tentzidou; M Xefteri; N Stangos
Journal:  Doc Ophthalmol       Date:  2000-11       Impact factor: 2.379

Review 7.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

8.  Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ann Halbower; Zhaoxing Pan; Kristen Robbins; Kelley E Capocelli; Jelena Klawitter; Colin T Shearn; Ronald J Sokol
Journal:  J Hepatol       Date:  2016-08-05       Impact factor: 25.083

9.  Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis.

Authors:  Oranan Siwamogsatham; Wei Dong; Jose N Binongo; Ritam Chowdhury; Jessica A Alvarez; Shawna J Feinman; Jessica Enders; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2014-04-17       Impact factor: 3.080

Review 10.  Dosage and formulation issues: oral vitamin E therapy in children.

Authors:  Tone Westergren; Betty Kalikstad
Journal:  Eur J Clin Pharmacol       Date:  2009-10-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.